Primary hyperoxaluria type 1: update and additional mutation analysis of the AGXT gene.
about
Protein trafficking defects in inherited kidney diseasesCrystal structure of the S187F variant of human liver alanine: Aminotransferase associated with primary hyperoxaluria type I and its functional implicationsMolecular Requirements for Peroxisomal Targeting of Alanine-Glyoxylate Aminotransferase as an Essential Determinant in Primary Hyperoxaluria Type 1The Role of Protein Denaturation Energetics and Molecular Chaperones in the Aggregation and Mistargeting of Mutants Causing Primary Hyperoxaluria Type ILigand-induced compaction of the PEX5 receptor-binding cavity impacts protein import efficiency into peroxisomesProtein homeostasis disorders of key enzymes of amino acids metabolism: mutation-induced protein kinetic destabilization and new therapeutic strategies.Mutational analysis of AGXT in two Chinese families with primary hyperoxaluria type 1.Selected AGXT gene mutations analysis provides a genetic diagnosis in 28% of Tunisian patients with primary hyperoxaluria.S81L and G170R mutations causing Primary Hyperoxaluria type I in homozygosis and heterozygosis: an example of positive interallelic complementation.Pharmacologic rescue of an enzyme-trafficking defect in primary hyperoxaluria 1.Performance evaluation of Sanger sequencing for the diagnosis of primary hyperoxaluria and comparison with targeted next generation sequencingPrimary hyperoxaluria.Allele-specific characterization of alanine: glyoxylate aminotransferase variants associated with primary hyperoxaluriaPrimary and secondary hyperoxaluria: Understanding the enigmaCharacteristics and outcomes of children with primary oxalosis requiring renal replacement therapyA rare case of hyperoxaluria presenting with acute liver injury and stone-free kidney injury.Phenotype-Genotype Correlations and Estimated Carrier Frequencies of Primary Hyperoxaluria.High throughput cell-based assay for identification of glycolate oxidase inhibitors as a potential treatment for Primary Hyperoxaluria Type 1Rapid profiling of disease alleles using a tunable reporter of protein misfolding.Novel findings in patients with primary hyperoxaluria type III and implications for advanced molecular testing strategiesTwo novel AGXT mutations identified in primary hyperoxaluria type-1 and distinct morphological and structural difference in kidney stonesGenetic determinants of urolithiasis.Vitamin B6 in primary hyperoxaluria I: first prospective trial after 40 years of practice.An update on primary hyperoxaluria.Hyperoxaluria and systemic oxalosis: an update on current therapy and future directions.Protein homeostasis defects of alanine-glyoxylate aminotransferase: new therapeutic strategies in primary hyperoxaluria type I.Liver-kidney transplantation in primary hyperoxaluria type-1: case report and literature review.Primary hyperoxalurias: diagnosis and treatment.Primary hyperoxaluria type 1 in 18 children: genotyping and outcome.Oxalate, inflammasome, and progression of kidney diseaseMutations in the Human Argininosuccinate Synthetase (ASS1) Gene, Impact on Patients, Common Changes, and Structural Considerations.Primary hyperoxaluria: spectrum of clinical and imaging findings.A novel mutation in the AGXT gene causing primary hyperoxaluria type I: genotype-phenotype correlation.Kidney injury molecule-1 is up-regulated in renal epithelial cells in response to oxalate in vitro and in renal tissues in response to hyperoxaluria in vivoPrimary hyperoxaluria in populations of Pakistan origin: results from a literature review and two major registries.Role of low native state kinetic stability and interaction of partially unfolded states with molecular chaperones in the mitochondrial protein mistargeting associated with primary hyperoxaluria.Effects of alanine:glyoxylate aminotransferase variants and pyridoxine sensitivity on oxalate metabolism in a cell-based cytotoxicity assay.Biochemical analyses are instrumental in identifying the impact of mutations on holo and/or apo-forms and on the region(s) of alanine:glyoxylate aminotransferase variants associated with primary hyperoxaluria type I.Primary Hyperoxaluria Type 1 with Homozygosity for a Double-mutated AGXT Allele in a 2-year-old Child.A novel mutation of human liver alanine:glyoxylate aminotransferase causes primary hyperoxaluria type 1: immunohistochemical quantification and subcellular distribution.
P2860
Q27012909-F36A36B6-DA8D-42A4-A0A1-56520BFF5105Q27677394-EA9294A6-6358-4591-8482-372C7714ECA6Q27678710-0D23969D-0D4F-4CE4-81DF-AF7A9FA451D6Q27680557-76E1603D-D699-4F2A-8E40-6FDEB5C6A9E4Q27696135-56BBCF35-17CA-4517-BAAE-3B89C939DC9AQ30355120-201784B2-AA58-45F0-80ED-DB3063696347Q33842031-3285F57C-BEF9-4895-A7B6-58AC490CDBFCQ33911824-C78E679D-8D93-40CF-B8DC-9EE277F6F196Q34379056-DCB199D4-23EB-4D57-ACD7-30296EA1831EQ34407663-D8E0C27A-20E8-4C84-AB05-6D1EBCA82F6EQ34987476-6AF33DC2-459E-4DC1-8731-CE414643610AQ35073045-2B7BB1CC-1F89-43A9-A6A1-B45198D0171AQ35144060-8FC40C39-9BBC-40BE-8405-501EF97E5C8DQ35567868-A93D948C-C698-4295-BA9D-68345B623F9EQ35827275-08BE999B-6057-4233-8903-A588D8E84705Q36061758-FC92C008-C87E-480F-9AC8-5E09718B96A2Q36104822-A1CCCC0C-721A-4A9E-8635-7E8FFC462415Q36145370-EBF0C1A7-4E5B-458B-91E2-D0B4B16E259AQ36466309-E82861C6-5CB1-46A7-AF9C-1A413A067751Q36543042-7D1A178F-EB92-4EDE-BCD9-FA457C8AED71Q37267462-605ABB45-319A-4FD2-B370-53AE5C64C679Q37512167-4DDF5E2A-9E95-4D33-AD3C-9378A12537F0Q37621553-DF7AEE23-3413-486E-8F73-F204819D8D4BQ38017938-7DF0B749-51C0-412E-87B3-217DEB79CEC8Q38061207-B33AD7F2-4F37-4785-A5E6-F70359511A20Q38129886-D824832A-0562-4846-BE9B-43E0C7D16E99Q38228334-E2392DDB-1CC1-43EF-9352-F0AF39A51FE7Q38292247-F95D322A-48D5-4978-AD44-D2D13163B6A5Q38445799-81A978DF-D3AA-481F-AE16-A19926EAC59AQ38837256-75D1FBBF-AD67-41D4-BFE5-6208979A1590Q39006194-F401B6F2-9C1E-427E-A5EF-4823CD374FE4Q39008793-89B7B483-B33F-4B03-AEC0-EC28362CC3A3Q39197697-5E34F90A-9D43-46B9-8535-B726F4012EA5Q39277424-6CFA008B-F7FA-4AD3-8560-95C551CB1C27Q39403849-F499434A-1634-4ADE-ACCB-49DBFEE8C9ACQ39628392-B5FEA9BC-496F-4727-AE9B-07664D7C7666Q40015456-F35F601B-159B-4A0F-A7C7-31FB0CC06042Q40821949-6746E167-FBFB-4B25-90AC-7679DD836F64Q41513887-03ED7129-174F-498E-84AB-86515C46B84BQ42002476-81D73E7A-C0D5-4E64-BA52-C628FC5B3087
P2860
Primary hyperoxaluria type 1: update and additional mutation analysis of the AGXT gene.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Primary hyperoxaluria type 1: update and additional mutation analysis of the AGXT gene.
@en
Primary hyperoxaluria type 1: update and additional mutation analysis of the AGXT gene.
@nl
type
label
Primary hyperoxaluria type 1: update and additional mutation analysis of the AGXT gene.
@en
Primary hyperoxaluria type 1: update and additional mutation analysis of the AGXT gene.
@nl
prefLabel
Primary hyperoxaluria type 1: update and additional mutation analysis of the AGXT gene.
@en
Primary hyperoxaluria type 1: update and additional mutation analysis of the AGXT gene.
@nl
P2093
P2860
P50
P356
P1433
P1476
Primary hyperoxaluria type 1: update and additional mutation analysis of the AGXT gene
@en
P2093
Angela Robbiano
Carla G Monico
Cecile Acquaviva
Eduardo Salido
Emma L Williams
Francoise Chevalier
Gill Rumsby
Hans Waterham
Tricia Owen
P2860
P304
P356
10.1002/HUMU.21021
P577
2009-06-01T00:00:00Z